Clinical Management of HCM: Medical, Invasive and Advanced Therapies


Clinical Management of HCM: Medical, Invasive, and Advanced Therapies

Doctor in mask looking off camera in dark surgery room Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn the latest in the clinical management of HCM in this free webinar.

Presenters: Anjali Tiku Owens, MD; Richard Bach, MD, FAHA, FACC, FSCAI
Moderator: James E. Udelson, MD, FAHA

Bristol Myers Squibb is a national sponsor of the American Heart Association’s hypertrophic cardiomyopathy initiative.

Anjali Owens MD

Anjali Tiku Owens, MD
Assistant Professor of Medicine
University of Pennsylvania

Richard Bach, MD, FAHA, FACC, FSCAI
Professor of Medicine, Medical Director - Cardiac ICU
Washington university School of Medicine

Dr. James E. Udelson, MD, FAHA
Chief, Division of Cardiology,
Tufts Medical Center